Biology, Vol. 14, Pages 1650: GLP-1 Receptor Signaling and Oral Dysfunction: A Narrative Review on the Mechanistic Basis of Semaglutide-Related Oral Adverse Effects

Biology, Vol. 14, Pages 1650: GLP-1 Receptor Signaling and Oral Dysfunction: A Narrative Review on the Mechanistic Basis of Semaglutide-Related Oral Adverse Effects Biology doi: 10.3390/biology14121650 Authors: Milena Barać Jelena Roganović This review addresses the growing concern of oral side effects, particularly dry mouth, associated with semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA) widely used […]

Nutrients, Vol. 17, Pages 3659: Macronutrient, Micronutrient Supplementation and Monitoring for Patients on GLP-1 Agonists: Can We Learn from Metabolic and Bariatric Surgery?

Nutrients, Vol. 17, Pages 3659: Macronutrient, Micronutrient Supplementation and Monitoring for Patients on GLP-1 Agonists: Can We Learn from Metabolic and Bariatric Surgery? Nutrients doi: 10.3390/nu17233659 Authors: Rhea Sibal G. Balamurugan Jasmine Langley Yitka Graham Kamal Mahawar Background/Objectives: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are increasingly prescribed for people living with obesity and type 2 diabetes […]

Eli Lilly Hits $1 Trillion Milestone on GLP-1 Boom

Eli Lilly Hits $1 Trillion Milestone on GLP-1 Boom Eli Lilly and Company BATS:LLY DEXWireNews Eli Lilly & Co. (NYSE: LLY ) briefly crossed the $1 trillion market-cap threshold, becoming the first health-care company in history to reach the valuation. Shares traded around $1,059 as demand for its GLP-1 weight-loss and diabetes drugs exploded, driving […]

Managing weight

The Ozempic era should change how we think about self-control Oh, oh, oh, Ozempic! The catchy jingle from Novo Nordisk’s 2018 TV commercial helped to popularise Ozempic and cement its name as a generic term for an entire category of drugs, now prescribed to millions of people to treat diabetes and obesity. An earworm, however, […]

Eli Lilly becomes first pharma firm to join $1 trillion club – Al Jazeera

Eli Lilly becomes first pharma firm to join $1 trillion club  Al Jazeera Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value  The New York Times Eli Lilly hits $1 trillion market value, a first for a health-care company  CNBC Is GLP-1 the new AI? Drugmaker Eli Lilly joins the $1 trillion market-cap club.  MarketWatch […]

Eli Lilly Tops $1 Trillion, Joins Tech Titans In Exclusive Club – Investor’s Business Daily

Eli Lilly Tops $1 Trillion, Joins Tech Titans In Exclusive Club  Investor’s Business Daily Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value  The New York Times Is GLP-1 the new AI? Drugmaker Eli Lilly joins the $1 trillion market-cap club.  MarketWatch Lilly becomes first healthcare firm to join trillion-dollar club, Wall Street reacts  Yahoo […]